This compound is primarily used in the field of medicinal chemistry, particularly in the development of pharmaceutical agents targeting the central nervous system. Its structure suggests potential activity as a modulator of neurotransmitter systems, making it a candidate for research in treating neurological disorders such as Parkinson's disease, schizophrenia, or depression. It may also be explored for its potential role in cognitive enhancement or as an analgesic. Additionally, its imidazolidinone and piperidine moieties make it a valuable intermediate in synthesizing more complex molecules with therapeutic applications. Researchers often utilize it in preclinical studies to evaluate its pharmacokinetic and pharmacodynamic properties.